Cases & Investigations
Berger & Montague was appointed co-lead class counsel to represent a class of physicians and other direct purchasers of vaccines from defendant Sanofi Pasteur Inc. (“Sanofi”). Plaintiffs charge that Sanofi has used a network of physician buying groups to implement a web of anticompetitive product bundling agreements.
The firm served as co-lead counsel in this antitrust price-fixing class action on behalf of a class of purchasers of brand name prescription drugs.
Berger & Montague is counsel to a proposed class of direct purchasers of aluminum and tantalum electrolytic capacitors and film capacitors.
Berger & Montague represented a class of direct purchasers of brand and generic Celebrex (celecoxib) in an action alleging that Pfizer, in violation of the Sherman Act, improperly obtained a patent for Celebrex from the U.S. Patent and Trademark Office in a scheme to unlawfully extend patent protection and delay market entry of generic versions of Celebrex.
Berger & Montague serves as one of the counsel on behalf of direct purchasers of containerboard products (which includes both linerboard, corrugated sheets and corrugated products such as boxes and other containers) in an antitrust class action against the largest domestic manufacturers of containerboard.
Berger & Montague has played a key role in In re CRT Antitrust Litigation, a case brought on behalf of a class of direct purchasers of cathode ray tubes (“CRTs”) or products containing CRTs, such as televisions and computer monitors, alleging that defendant manufacturers conspired to fix the prices of CRTs.
Berger & Montague represents a proposed class of similarly situated current and former UFC professional combatants, alleging that the plaintiffs are victims of the UFC’s illegal scheme to eliminate its competition in the sport of MMA and suppress compensation for UFC Fighters from bouts and fighter identities and likenesses.
This action was brought on behalf of a class of United States holders of Visa, MasterCard, and Diners Club credit or charge cards who incurred fees on credit card transactions in a foreign currency or with a foreign merchant. The class action alleges that the defendants conspired to artificially set and inflate currency conversion fees United States cardholders incur each time they use their cards in foreign currency transactions or with a foreign merchant. The action also alleges that defendants violated their disclosure obligations under Truth In Lending Act to disguise these fixed conversion fees from cardholders.
Berger & Montague serves as co-lead counsel for a proposed class of dental practices and dental laboratories in a suit brought against Henry Schein, Inc., Patterson Companies, Inc., and Benco Dental Supply Company, the three largest distributors of dental supplies in the United States.
Berger & Montague P.C. represents a class of persons or entities that purchased brand or generic Effexor XR directly from Wyeth, Inc. or Teva Pharmaceuticals USA, Inc. in a case alleging unlawful efforts to delay generic entry.